SCHEMBL23904398

SCHEMBL23904398

CCC(=O)N(C)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
CA14 Q9ULX7 3/20 0.33
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA7 P43166 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CTSL P07711 2/20 0.31
CTSB P07858 2/20 0.31
CTSS P25774 2/20 0.31
DGAT1 O75907 1/20 0.31
CTSD P07339 1/20 0.31
SOAT1 P35610 1/20 0.31
ASGR1 P07306 1/20 0.31
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19008534 0.83 HDAC1 (0.42) HDAC6HDAC1HDAC2NFKB1NFKB2
SCHEMBL2246456 0.83 HDAC6 (0.41) HDAC6HDAC1HDAC2NFKB1NFKB2
SCHEMBL8737769 0.81 HDAC6 (0.39) HDAC6HDAC1HDAC2NFKB1NFKB2
SCHEMBL24737134 0.81 NFKB1 (0.45) HDAC6HDAC1HDAC2NFKB1NFKB2
SCHEMBL19821408 0.80 ALDH1A1 (0.50) HDAC6HDAC1HDAC2NFKB1NFKB2
SCHEMBL21470872 0.79 HDAC6 (0.50) HDAC6HDAC1HDAC2MEN1KMT2A
SCHEMBL17277202 0.78 HDAC6 (0.41) HDAC6HDAC1HDAC2NFKB1NFKB2
SCHEMBL28595621 0.78 PHF8 (0.45) HDAC6HDAC1HDAC2NFKB1NFKB2
SCHEMBL17934111 0.78 HDAC6 (0.38) HDAC6HDAC1HDAC2NFKB1NFKB2
SCHEMBL17934204 0.75 HDAC6 (0.39) HDAC6HDAC1HDAC2NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021202796-A1 PYRROLIDINE-PYRAZOLES AS PYRUVATE KINASE ACTIVATORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-10-07 WO disclosed